BR0213964A - sistema de expressão de ácido nucléico regulada - Google Patents

sistema de expressão de ácido nucléico regulada

Info

Publication number
BR0213964A
BR0213964A BRPI0213964-2A BR0213964A BR0213964A BR 0213964 A BR0213964 A BR 0213964A BR 0213964 A BR0213964 A BR 0213964A BR 0213964 A BR0213964 A BR 0213964A
Authority
BR
Brazil
Prior art keywords
nucleic acid
expression system
acid expression
regulated nucleic
expression
Prior art date
Application number
BRPI0213964-2A
Other languages
English (en)
Inventor
Yung-Nien Chang
Yajin Ni
Boro Dropulic
Original Assignee
Virxsys Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virxsys Corp filed Critical Virxsys Corp
Publication of BR0213964A publication Critical patent/BR0213964A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16051—Methods of production or purification of viral material
    • C12N2740/16052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"SISTEMA DE EXPRESSãO DE áCIDO NUCLéICO REGULADA". A presente invenção refere-se a constructos de ácido nucléico, sistemas de expressão e métodos relatando a regulação de expressão de gene. A invenção pode ser aplicada para regular a expressão de qualquer seqüência de codificação de interesse, incluindo aquelas codificações para componentes virais necessários para o empacotamento de partículas virais.
BRPI0213964-2A 2001-10-30 2002-10-30 sistema de expressão de ácido nucléico regulada BR0213964A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/020,472 US6835568B2 (en) 2001-10-30 2001-10-30 Regulated nucleic acid expression system
PCT/US2002/034932 WO2003054210A2 (en) 2001-10-30 2002-10-30 Regulated nucleic acid expression system

Publications (1)

Publication Number Publication Date
BR0213964A true BR0213964A (pt) 2006-05-30

Family

ID=21798805

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0213964-2A BR0213964A (pt) 2001-10-30 2002-10-30 sistema de expressão de ácido nucléico regulada

Country Status (15)

Country Link
US (2) US6835568B2 (pt)
EP (1) EP1446488A4 (pt)
JP (1) JP2005512573A (pt)
KR (1) KR100984268B1 (pt)
CN (1) CN100591769C (pt)
AU (1) AU2002365090B2 (pt)
BR (1) BR0213964A (pt)
CA (1) CA2464268C (pt)
CZ (1) CZ2004546A3 (pt)
IL (2) IL161495A0 (pt)
MX (1) MXPA04003969A (pt)
NO (1) NO20041763L (pt)
NZ (1) NZ533132A (pt)
RU (1) RU2004116319A (pt)
WO (1) WO2003054210A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297536B2 (en) * 2003-01-23 2007-11-20 Wisconsin Alumni Research Foundation Inducible protein expression system
US20090123494A1 (en) * 2007-07-31 2009-05-14 William Staplin Momlv-based pseudovirion packaging cell line
EP2271754A4 (en) * 2008-03-28 2013-01-16 Virxsys Corp IMMUNOGENIC VECTORS BASED ON LENTIVIRUS
BR112012010755A2 (pt) * 2009-11-05 2015-09-22 Proyecto Biomedicina Cima Sl constructo de gene que permite a expressão hepato-específica induzível de um polinucleotídeo de interesse em resposta a um agente indutor, vetor, genoma viral recombinante, vírion, método in vitro para a expressão de um polinucleotídeo de interesse em uma célula de origem hepática, composição farmacêutica e operador-promotor bi-direcional induzível adequado para a expressão hepato-específica induzível de dois polinucleotídeos de interesse por um agente indutor
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
US9347065B2 (en) 2012-03-29 2016-05-24 International Aids Vaccine Initiative Methods to improve vector expression and genetic stability
ES2939617T3 (es) 2015-11-24 2023-04-25 Glaxosmithkline Ip Dev Ltd Líneas celulares estables para producción retroviral
DE102016122317A1 (de) 2015-11-24 2017-05-24 Glaxosmithkline Intellectual Property Development Limited Transientes transfektionsverfahren für retrovirale produktion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0449116B2 (en) 1990-03-21 2004-08-25 Geneart GmbH DNA sequences encoding modified retroviral gag polypeptides and vaccines containing them or aggregates thereof
US6174666B1 (en) 1992-03-27 2001-01-16 The United States Of America As Represented By The Department Of Health And Human Services Method of eliminating inhibitory/instability regions from mRNA
US5750396A (en) 1995-05-08 1998-05-12 St. Judes Children's Research Hospital Stable virus packaging cell lines
US5885806A (en) 1995-11-28 1999-03-23 The Johns Hopkins University School Of Medicine Methods to prepare conditionally replicating viral vectors
US5888767A (en) 1996-11-27 1999-03-30 The Johns Hopkins University School Of Medicine Method of using a conditionally replicating viral vector to express a gene
US6133027A (en) * 1996-08-07 2000-10-17 City Of Hope Inducible expression system
GB9803351D0 (en) 1998-02-17 1998-04-15 Oxford Biomedica Ltd Anti-viral vectors
HUP0201019A2 (en) 1999-04-26 2002-08-28 Leuven K U Res & Dev Synthetic gene for expressing active retroviral protein in eukaryotes

Also Published As

Publication number Publication date
US6835568B2 (en) 2004-12-28
NZ533132A (en) 2008-04-30
KR100984268B1 (ko) 2010-09-30
AU2002365090B2 (en) 2007-12-20
CA2464268A1 (en) 2003-07-03
WO2003054210A2 (en) 2003-07-03
KR20040066799A (ko) 2004-07-27
US20060121579A1 (en) 2006-06-08
IL161495A0 (en) 2004-09-27
CA2464268C (en) 2012-03-20
WO2003054210B1 (en) 2004-02-26
RU2004116319A (ru) 2005-03-27
WO2003054210A3 (en) 2003-12-24
MXPA04003969A (es) 2004-07-08
NO20041763L (no) 2004-04-29
JP2005512573A (ja) 2005-05-12
IL161495A (en) 2009-06-15
EP1446488A4 (en) 2004-12-22
US8043611B2 (en) 2011-10-25
CN1578837A (zh) 2005-02-09
EP1446488A2 (en) 2004-08-18
US20030087419A1 (en) 2003-05-08
CZ2004546A3 (cs) 2004-10-13
AU2002365090A1 (en) 2003-07-09
CN100591769C (zh) 2010-02-24

Similar Documents

Publication Publication Date Title
ATE532860T1 (de) B7-ähnliche moleküle und deren anwendungen
BRPI0516463A (pt) cánula escalonada e conjunto de cánula
BR9810870A (pt) Regulação de expressão de quinolato fosforibosil transferase
HUP0302128A2 (hu) Anti-duális-integrin ellenanyagok, készítmények, eljárások és alkalmazások
BRPI0315652B8 (pt) molécula de ácido nucleico isolada, vetor, polipeptídeo de fusão, e, multímero
ATE437222T1 (de) Alphavirus replikon-vektorsysteme
WO2001079442A3 (en) Albumin fusion proteins
WO2005003296A3 (en) Albumin fusion proteins
DE69833649D1 (de) Ef-1-alpha transkriptionsregulatorische dna aus hamster
WO2003089618A3 (en) Transposon system and methods of use
BR9713294A (pt) "anticorpos contra proteìna relacionada a hormÈnio de paratiróide humano"
PL407889A1 (pl) Przeciwciało przeciwko receptorowi insulinopodobnego czynnika wzrostu I, zawierająca go kompozycja farmaceutyczna, sposób jego wytwarzania, zastosowania, linia komórkowa, wyizolowana cząsteczka kwasu nukleinowego, wektor, komórka gospodarza oraz zwierzę trangeniczne
WO2002090600A3 (en) A method for regulating immune function in primates using the foxp3 protein
BR0213964A (pt) sistema de expressão de ácido nucléico regulada
BR0205161A (pt) Pó de poliamida com valor do ph ajustado para empregos cosméticos
BR0013728A (pt) Sequências reguladoras de plantas para controle seletivo de expressão de gene
ATE414711T1 (de) Polymerstabilisierte proteinasen
AU2003286008A1 (en) Method for preparing emulsions
BR0008766A (pt) Sistema de vetor de rna de componente múltiplo para expressão de sequências estranhas
BR0315055A (pt) Diamidas de ácido pirimidin-4,6-dicarboxìilco para a inibição seletiva de colagenases
BR0011469A (pt) Gm-csf equina
ATE213776T1 (de) (s)-hydroxynitrillyase aus hevea brasiliensis
WO2001088124A3 (en) Method and reagent for the inhibition of erg
BR9910787A (pt) Métodos e composições úteis para modulação deangiogênese usando tirosina cinase src
WO2003102017A3 (en) Anti-relp fusion antibodies, compositions, methods and uses

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]